4-Nitro-3-(trifluoromethyl)acetanilide, 97.0%, 10g

(3-Chloro-4-(pyrrolidine-1-carbonyl)phenyl)boronic acid, 95.0%, 100mg

trimethyl (S)-5-((3-phenoxybenzyl)(1,2,3,4-tetrahydronaphthalen-1-yl)carbamoyl)benzene-1,2,4-tricarboxylate, 98%, 100mg

4-Chloro-2-fluoro-1-(methoxymethoxy)benzene, 98%, 5g

2-Amino-6-(trifluoromethyl)benzoic acid hydrochloride, 97.0%, 1g

Ethyl 4-(Chloromethyl)benzoate>98.0%(GC)25g

1-TOSYLAZETIDIN-3-OL, 95.0%, 250mg

2,3-Dicyanohydroquinone, 99.0%, 10g

Ethyl 3-aminopyridazine-4-carboxylate, 95.0%, 250mg

2-Fluoro-6-(trifluoromethyl)benzaldehyde>98.0%(GC)1g

2-(3-(Difluoromethoxy)-4-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

Cubetas de electroporación 850 µl, 50 uds 50 uds

2,3,7,8,12,13,17,18-Octafluoro-5,10,15,20-tetrakis(pentafluorophenyl)porphyrin>98.0%(HPLC)100mg